Saxenburgh Medisch Centrum

At Saxenburgh Medisch Centrum, most of the clinical research focuses on cardiovascular disease, especially efforts to lower heart attack and stroke risk, improve care in atrial fibrillation, and support patients with heart failure and related complications.

• Testing new approaches to reduce major cardiovascular events in high-risk patients
• Studying treatments for stroke prevention in atrial fibrillation
• Evaluating therapies for heart failure, including cases with kidney impairment
• Assessing medicines aimed at lowering elevated lipoprotein(a) and related cardiovascular risk

These studies are designed to improve prevention, treatment effectiveness, and long-term outcomes in people with established or high-risk cardiovascular conditions.

The site also supports research in nutritional and metabolic diseases, with trials involving type 2 diabetes and conditions linked to metabolic risk that can affect the heart and kidneys.

• Evaluating a new treatment option for people with type 2 diabetes and high cardiovascular risk
• Studying therapies that may improve outcomes in patients with metabolic disease and cardiovascular complications
• Exploring ways to reduce the burden of diabetes-related cardiovascular events

These trials aim to strengthen disease control while also lowering the chance of serious heart-related events in people with complex metabolic illness.

Research in hormonal diseases at this hospital includes studies in hypothyroidism, with attention to patients who continue to experience symptoms despite standard treatment.

• Comparing treatment strategies for persistent tiredness in autoimmune hypothyroidism
• Investigating whether combination hormone therapy may better relieve ongoing symptoms
• Looking at whether certain genetic factors influence response to thyroid treatment

This work is aimed at improving symptom relief and helping clinicians better tailor treatment for people living with thyroid-related disorders.

The oncology-related research at Saxenburgh Medisch Centrum includes studies in breast cancer and multiple myeloma, focusing on better treatment strategies and disease control.

• Testing treatment sequences for hormone receptor-positive breast cancer to improve disease control
• Assessing whether a treatment-free interval may be feasible in newly diagnosed multiple myeloma
• Exploring ways to improve progression-free survival and overall cancer management

These trials are intended to refine cancer care by finding approaches that may extend benefit while supporting patient quality of life.